Article
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.
Psychopharmacology - 1 Oct 2008
Labrie Viviane, Lipina Tatiana, Roder John C
Abstract excerpt
RATIONALE: Schizophrenic patients demonstrate prominent negative and cognitive symptoms that are poorly responsive to antipsychotic treatment. Abnormal glutamatergic neurotransmission may contribute to these pathophysiological dimensions of schizophrenia. OBJECTIVE: We examined the involvement of the glycine coagonist site on the N-methyl-D: -aspartate receptor (NMDAR) glycine coagonist site in the modulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
